What is the standard route of administration for enoxaparin in DVT prophylaxis?

Enoxaparin, a low molecular weight heparin, is used primarily in the prevention and treatment of deep vein thrombosis (DVT). The standard route for administering enoxaparin for DVT prophylaxis is subcutaneous. This administration method allows for effective absorption and therapeutic levels in the bloodstream while minimizing the risk of complications associated with intravenous or intramuscular routes.

Subcutaneous administration involves injecting the medication into the fatty tissue just beneath the skin, which is ideal for medications like enoxaparin, as it promotes gradual absorption and maintains stable anticoagulant levels over time. The subcutaneous route is also less invasive and more comfortable for patients compared to intravenous or intramuscular options, making it the preferred choice for this indication. Additionally, enoxaparin is formulated and dosed specifically for subcutaneous use in DVT prophylaxis, ensuring both safety and efficacy in preventing clot formation.